Scientists test engineered immune cells to fight tough cancers
NCT ID NCT07474168
Summary
This early-stage study is testing the safety of a new type of personalized cell therapy called NW-301VT for people with advanced solid tumors that have a specific genetic change (KRAS G12V mutation). About 9 participants will have their own immune cells collected, genetically modified to better target the cancer, and then infused back into their body. The main goal is to see if this treatment is safe and to find the right dose, while also checking for any early signs that it might help shrink tumors.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affiliated Hospital of Zhejiang University school of Medicine
Hangzhou, Zhejiang, China
Conditions
Explore the condition pages connected to this study.